A global leader in immuno-oncology approached us for support with over 50 simple to complex Development Safety Update Reports (DSURs) with tight timelines.
Below, we explore how we worked with the client to implement a streamlined process leveraging expert Safety/Pharmacovigilance (PV) writers and planning tools in order to achieve success.

Download our white paper to learn more about harmonizing pharmacovigilance documents like DSURs, Risk Management Plans (RMPs), and Periodic Safety Update Reports (PSURs).
联系我们